News | September 11, 2008

GE, Varian to Develop PreClinical 7T MRI

September 12, 2008 – GE Healthcare and Varian Inc. will begin a collaboration to develop a new preclinical 7T magnetic resonance (MR) imaging system to create an advanced MR for research purposes.

Under the agreement, initial development and integration will be a joint effort between the two companies. Once development is complete, Varian will offer customers a fully integrated 7T System combining GE Healthcare’s electronics, user interface, pulse-sequences and applications with the magnet, gradients, positioning devices and RF coils provided by Varian.

“Pre-clinical imaging is a key area of growth for Varian," said Garry Rogerson, president and CEO, Varian, Inc.

Preclinical magnetic resonance imaging is a versatile and noninvasive method to investigate anatomy, metabolism and physiology in research models. It has a broad range of applications in soft tissues, including brain and organ imaging, tumor assessment, disease progression, and functional imaging. In research, other potential applications include investigation of new contrast mechanisms and agents, monitoring gene expression, analysis of protein interactions, and determination of pharmacokinetics. Magnetic resonance spectroscopy imaging is a closely related technique, used to measure the concentrations of specific molecules in the body, enabling direct measurement of neurotransmitters in the brain or metabolites in muscle.

“We feel this system is an ideal addition to our existing pre-clinical MRI product line,” said Martin O’Donoghue, Vice President, Scientific Instruments, Varian, Inc. “It will appeal to the burgeoning group of researchers who have experience with GE MRI systems. We feel this will give them the pre-clinical MR imaging tool they have been looking for.”

According to Jim Mitchell, general manager of Molecular Imaging technologies for GE Healthcare, the company together with Varian anticipates expanding its preclinical imaging offering which currently includes PET, SPECT, CT scanners as well as dual and tri-modality imaging systems.

For more information: www.gehealthcare.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing